(Q47830704)

6 February 2018

review article

1 reference

title

Angiotensin, LDL peroxidation and atherosclerosis. (English)

1 reference

6 February 2018

1 reference

Keidar S

1

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 January 1998

1 reference

6 February 2018

published in

Life Sciences

1 reference

6 February 2018

volume

63

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

1-11

1 reference

6 February 2018

Chymase-dependent angiotensin II forming systems in humans

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Circulating and tissue angiotensin systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Evidence that angiotensin II is present in human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Renin is expressed in rat macrophage/monocyte cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Bovine and human endothelial cell production of neutrophil chemoattractant activity in response to components of the angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Activation of human peripheral monocytes by angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Human platelet angiotensin II receptors: regulation by the circulating angiotensin level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Autoradiographic localization of angiotensin-converting enzyme and angiotensin II binding sites in early atheroma-like lesions in rabbit arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Stimulation of rat vascular smooth muscle cell glycosaminoglycan production by angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II activates programmed myocyte cell death in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Modified forms of low density lipoprotein and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: a possible role for angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Role of oxygen-derived free radicals in acute angiotensin II--induced hypertensive vascular disease in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Role of oxidized low density lipoprotein in atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900014-9

10.1016/S0024-3205(98)00014-9

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018